Metagenomics is the process of cloning and analyzing the genomes of an organism without culturing them in a community.
Highlights
The global Metagenomics Sequencing market was valued at US$ 917 million in 2022 and is anticipated to reach US$ 1592.7 million by 2029, witnessing a CAGR of 9.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major factors driving the growth of the global metagenomics market include technological advancements in DNA sequencing. Moreover, metagenomics is applicable across a broad range of areas such as agriculture, environmental bioremediation, gut microbe characterization and others.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Metagenomics Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomics Sequencing.
The Metagenomics Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Metagenomics Sequencing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metagenomics Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Agilent Technologies
Enterome SA
F. Hoffmann
Illumina
Oxford Nanopore Technologies
Pacific Biosciences of California
PerkinElmer
Qiagen
Swift Biosciences
Thermo Fisher Scientific
Segment by Type
Instrument and Software
Consumables
Segment by Application
Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metagenomics Sequencing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Metagenomics Sequencing 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Instrument and Software
1.2.3 Consumables
1.3 麻豆原创 by Application
1.3.1 Global Metagenomics Sequencing 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Disease Diagnosis
1.3.3 Environmental Remediation
1.3.4 Gut Microbe Characterization
1.3.5 Biotechnology
1.3.6 Biofuel
1.3.7 Agriculture
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metagenomics Sequencing 麻豆原创 Perspective (2018-2029)
2.2 Metagenomics Sequencing Growth Trends by Region
2.2.1 Global Metagenomics Sequencing 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Metagenomics Sequencing Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Metagenomics Sequencing Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Metagenomics Sequencing 麻豆原创 Dynamics
2.3.1 Metagenomics Sequencing Industry Trends
2.3.2 Metagenomics Sequencing 麻豆原创 Drivers
2.3.3 Metagenomics Sequencing 麻豆原创 Challenges
2.3.4 Metagenomics Sequencing 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metagenomics Sequencing Players by Revenue
3.1.1 Global Top Metagenomics Sequencing Players by Revenue (2018-2023)
3.1.2 Global Metagenomics Sequencing Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Metagenomics Sequencing 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metagenomics Sequencing Revenue
3.4 Global Metagenomics Sequencing 麻豆原创 Concentration Ratio
3.4.1 Global Metagenomics Sequencing 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metagenomics Sequencing Revenue in 2022
3.5 Metagenomics Sequencing Key Players Head office and Area Served
3.6 Key Players Metagenomics Sequencing Product Solution and Service
3.7 Date of Enter into Metagenomics Sequencing 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Metagenomics Sequencing Breakdown Data by Type
4.1 Global Metagenomics Sequencing Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Metagenomics Sequencing Forecasted 麻豆原创 Size by Type (2024-2029)
5 Metagenomics Sequencing Breakdown Data by Application
5.1 Global Metagenomics Sequencing Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Metagenomics Sequencing Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Metagenomics Sequencing 麻豆原创 Size (2018-2029)
6.2 North America Metagenomics Sequencing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Metagenomics Sequencing 麻豆原创 Size by Country (2018-2023)
6.4 North America Metagenomics Sequencing 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metagenomics Sequencing 麻豆原创 Size (2018-2029)
7.2 Europe Metagenomics Sequencing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Metagenomics Sequencing 麻豆原创 Size by Country (2018-2023)
7.4 Europe Metagenomics Sequencing 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metagenomics Sequencing 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Metagenomics Sequencing 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Metagenomics Sequencing 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Metagenomics Sequencing 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metagenomics Sequencing 麻豆原创 Size (2018-2029)
9.2 Latin America Metagenomics Sequencing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Metagenomics Sequencing 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Metagenomics Sequencing 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metagenomics Sequencing 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Metagenomics Sequencing 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Metagenomics Sequencing 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Metagenomics Sequencing 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Metagenomics Sequencing Introduction
11.1.4 Agilent Technologies Revenue in Metagenomics Sequencing Business (2018-2023)
11.1.5 Agilent Technologies Recent Development
11.2 Enterome SA
11.2.1 Enterome SA Company Detail
11.2.2 Enterome SA Business Overview
11.2.3 Enterome SA Metagenomics Sequencing Introduction
11.2.4 Enterome SA Revenue in Metagenomics Sequencing Business (2018-2023)
11.2.5 Enterome SA Recent Development
11.3 F. Hoffmann
11.3.1 F. Hoffmann Company Detail
11.3.2 F. Hoffmann Business Overview
11.3.3 F. Hoffmann Metagenomics Sequencing Introduction
11.3.4 F. Hoffmann Revenue in Metagenomics Sequencing Business (2018-2023)
11.3.5 F. Hoffmann Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Metagenomics Sequencing Introduction
11.4.4 Illumina Revenue in Metagenomics Sequencing Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Oxford Nanopore Technologies
11.5.1 Oxford Nanopore Technologies Company Detail
11.5.2 Oxford Nanopore Technologies Business Overview
11.5.3 Oxford Nanopore Technologies Metagenomics Sequencing Introduction
11.5.4 Oxford Nanopore Technologies Revenue in Metagenomics Sequencing Business (2018-2023)
11.5.5 Oxford Nanopore Technologies Recent Development
11.6 Pacific Biosciences of California
11.6.1 Pacific Biosciences of California Company Detail
11.6.2 Pacific Biosciences of California Business Overview
11.6.3 Pacific Biosciences of California Metagenomics Sequencing Introduction
11.6.4 Pacific Biosciences of California Revenue in Metagenomics Sequencing Business (2018-2023)
11.6.5 Pacific Biosciences of California Recent Development
11.7 PerkinElmer
11.7.1 PerkinElmer Company Detail
11.7.2 PerkinElmer Business Overview
11.7.3 PerkinElmer Metagenomics Sequencing Introduction
11.7.4 PerkinElmer Revenue in Metagenomics Sequencing Business (2018-2023)
11.7.5 PerkinElmer Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Detail
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Metagenomics Sequencing Introduction
11.8.4 Qiagen Revenue in Metagenomics Sequencing Business (2018-2023)
11.8.5 Qiagen Recent Development
11.9 Swift Biosciences
11.9.1 Swift Biosciences Company Detail
11.9.2 Swift Biosciences Business Overview
11.9.3 Swift Biosciences Metagenomics Sequencing Introduction
11.9.4 Swift Biosciences Revenue in Metagenomics Sequencing Business (2018-2023)
11.9.5 Swift Biosciences Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Metagenomics Sequencing Introduction
11.10.4 Thermo Fisher Scientific Revenue in Metagenomics Sequencing Business (2018-2023)
11.10.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Agilent Technologies
Enterome SA
F. Hoffmann
Illumina
Oxford Nanopore Technologies
Pacific Biosciences of California
PerkinElmer
Qiagen
Swift Biosciences
Thermo Fisher Scientific
听
听
*If Applicable.
